Wesana Health

Lucy Scientific Discovery Inc. (NASDAQ: LSDI) completed its acquisition of Wesana Health Inc.'s SANA-013 assets. SANA-013 is being developed for the treatment of several mental health and central nervous system related conditions, including major depressive disorder, migraine, episodic cluster...

A number of financial firms and investment banks initiated coverage of Atai Life Sciences (NASDAQ: ATAI) last week. Ratings ranged from a sober sector performance rating from RBC Capital Markets with a $19 12-month price target to a bullish Overweight rating from Cantor Fitzgerald,...

On Monday, Wesana Health Holdings Inc. announced that its shares began trading on the Canadian Securities Exchange under the ticker symbol “WESA.” The company, founded by former NHL left-winger Daniel Carcillo, is focused on finding novel solutions for treating traumatic brain injury (...

Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound. The Multidisciplinary Association for Psychedelic Studies released the results from its Phase 3 trial on MDMA for the treatment of post-traumatic...

First Psychedelics ETF Debuts On NEO Exchange Psychedelics’ first exchange traded fund went public last Wednesday. The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK’, and managed by Horizons ETFs Management. PSYK is a...